|
1
|
Weller M: Novel diagnostic and therapeutic
approaches to malignant glioma. Swiss Med Wkly.
141:w132102011.PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen P and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kohlhase J, Schuh R, Dowe G, Kühnlein RP,
Jäckle H, Schroeder B, Schulz-Schaeffer W, Kretzschmar HA, Köhler
A, Müller U, et al: Isolation, characterization, and organ-specific
expression of two novel human zinc finger genes related to the
Drosophila gene spalt. Genomics. 38:291–298. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY,
Soh BS, Lou Y, Yang J, Ma Y, Chai L, et al: Sall4 modulates
embryonic stem cell pluripotency and early embryonic development by
the transcriptional regulation of Pou5f1. Nat Cell Biol.
8:1114–1123. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Gao C, Chai L and Ma Y: A novel
SALL4/OCT4 transcriptional feedback network for pluripotency of
embryonic stem cells. PLoS One. 5:e107662010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
8
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobayashi D, Kuribayashi K, Tanaka M and
Watanabe N: Overexpression of SALL4 in lung cancer and its
importance in cell proliferation. Oncol Rep. 26:965–970.
2011.PubMed/NCBI
|
|
11
|
Kobayashi D, Kuribayshi K, Tanaka M and
Watanabe N: SALL4 is essential for cancer cell proliferation and is
overexpressed at early clinical stages in breast cancer. Int J
Oncol. 38:933–939. 2011.PubMed/NCBI
|
|
12
|
Yong KJ, Gao C, Lim JS, Yan B, Yang H,
Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, et al: Oncofetal
gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med.
368:2266–2276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aguila JR, Liao W, Yang J, Avila C, Hagag
N, Senzel L and Ma Y: SALL4 is a robust stimulator for the
expansion of hematopoietic stem cells. Blood. 118:576–585. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang J, Aguila JR, Alipio Z, Lai R, Fink
LM and Ma Y: Enhanced self-renewal of hematopoietic stem/progenitor
cells mediated by the stem cell gene Sall4. J Hematol Oncol.
4:382011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Yan Y, Jiang Y, Cui Y, Zou Y,
Qian J, Luo C, Lu Y and Wu X: The expression of SALL4 in patients
with gliomas: High level of SALL4 expression is correlated with
poor outcome. J Neurooncol. 121:261–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM,
Lai R, Ritz J, Krause DS and Chai L: SALL4, a novel oncogene, is
constitutively expressed in human acute myeloid leukemia (AML) and
induces AML in transgenic mice. Blood. 108:2726–2735. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng L, Alexander R, Zhang S, Pan CX,
MacLennan GT, Lopez-Beltran A and Montironi R: The clinical and
therapeutic implications of cancer stem cell biology. Expert Rev
Anticancer Ther. 11:1131–1143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Y, Liu S, Wang P, Zhao S, Wang F, Bing
L, Zhang Y, Ling EA, Gao J and Hao A: Expression of embryonic stem
cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Histopathology. 59:763–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holmberg J, He X, Peredo I, Orrego A,
Hesselager G, Ericsson C, Hovatta O, Oba-Shinjo SM, Marie SK,
Nistér M and Muhr J: Activation of neural and pluripotent stem cell
signatures correlates with increased malignancy in human glioma.
PLoS One. 6:e184542011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen DW, Pouliot LM, Hall MD and Gottesman
MM: Cisplatin resistance: A cellular self-defense mechanism
resulting from multiple epigenetic and genetic changes. Pharmacol
Rev. 64:706–721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hiddingh L, Raktoe RS, Jeuken J, Hulleman
E, Noske DP, Kaspers GJ, Vandertop WP, Wesseling P and Wurdinger T:
Identification of temozolomide resistance factors in glioblastoma
via integrative miRNA/mRNA regulatory network analysis. Sci Rep.
4:52602014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaina B, Christmann M, Naumann S and Roos
WP: MGMT: Key node in the battle against genotoxicity,
carcinogenicity and apoptosis induced by alkylating agents. DNA
Repair (Amst). 6:1079–1099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng SS, Yamashita T, Kondo M, Nio K,
Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, et al:
The transcription factor SALL4 regulates stemness of EpCAM-positive
hepatocellular carcinoma. J Hepatol. 60:127–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitange GJ, Mladek AC, Carlson BL,
Schroeder MA, Pokorny JL, Cen L, Decker PA, Wu W, Lomberk GA, Gupta
SK, et al: Inhibition of histone deacetylation potentiates the
evolution of acquired temozolomide resistance linked to MGMT
upregulation in glioblastoma xenografts. Clin Cancer Res.
18:4070–4079. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim HS, Kim NC, Chae KH, Kim G, Park WS,
Park YK and Kim YW: Expression of multidrug resistance-associated
protein 2 in human gallbladder carcinoma. Biomed Res Int.
2013:5275342013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chamberlain MC, Bota DA, Linskey ME and
Schwartz PH: Neural stem/progenitors and glioma stem-like cells
have differential sensitivity to chemotherapy. Neurology.
77:e135–e136. 2011. View Article : Google Scholar : PubMed/NCBI
|
